Advanced Therapies Integrates 2022
CELLULAR GROWTH
How do you secure VC investment? This track focuses on how to develop and present your advanced therapy innovation to secure investment.
TECH TO TRANSLATE
Discover the scientific and technological innovations to support your ATMP getting to market.
MAKING IT
Discover how to manufacture your ATMPs, outsourced or in-house, and the process and analytical technology innovation that underpins success.
Registration and Networking
Registration and Networking
Welcome & Opening Remarks
Welcome & Opening Remarks
MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult
Fireside Chat
Fireside Chat
Interviewed by:Â MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult
Fireside Chat
Fireside Chat
Session 1
Viable cells to viable sells
How do you develop an investible opportunity that is commercially viable?
On Target
Identifying the best targets, using AI, BioInformatics and ‘Omics’ approaches to improve biological understanding and predict efficacy and pharmacology for cell and gene therapies.
Innovate to Elevate
Discover how Process Analytical Technology can improve your ATMP manufacturing and scale up.
Session 2
Pitch perfect: advancing therapies
How to present an investible opportunity, focusing on pitching, partnering and funding opportunities.
Prepare for patients
What should you consider when getting an advanced therapy ready for First in Human trials? Does it have the 5Rs: right target, right tissue, right safety, right patient and right commercial potential?
Matchmaking
How to find the right partner to outsource your manufacturing and the considerations for setting up a productive partnership.
Session 3
VC judges: what is the X factor?
What are VC Investors looking for at different stages of the life cycle? How is the current economic environment impacting Venture Capital?
Advancing into the clinic
What do you need to consider to progress advanced therapies through the clinical phase of development?
ATMP: house blend
Understand when to keep manufacturing in-house and what you need to consider to make that a success e.g. what expertise and skills are required.
Session 4
Healthy Economics for thriving ATMPs
How do you plan ATMP Health Economics for early-stage R&D, ensuring commercial viability?
License to thrill: ATMPs
How do you get a licence to market your ATMP? What to consider when thinking about post-marketing commitments and surveillance.
Oh Industry 4.0
How has Industry 4.0 been adopted and where should the focus be? Our panel discusses digitalisation, sensors and automation, security and sustainability.
Closing Remarks
Closing Remarks
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.
Advanced Therapies Integrates 2022
Registration and Networking
Welcome & Opening Remarks
MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult
Fireside Chat
An interview with: MARTIN MURPHY | Chief Executive Officer | Syncona Investment Management Limited
Interviewed by:Â MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult
Fireside Chat
CELLULAR GROWTH
How do you secure VC investment? This track focuses on how to develop and present your advanced therapy innovation to secure investment.
Viable cells to viable sells
How do you develop an investible opportunity that is commercially viable?
Pitch perfect: advancing therapies
How to present an investible opportunity, focusing on pitching, partnering and funding opportunities.
VC judges: what is the X factor?
What are VC Investors looking for at different stages of the life cycle? How is the current economic environment impacting Venture Capital?
Healthy Economics for thriving ATMPs
How do you plan ATMP Health Economics for early-stage R&D, ensuring commercial viability?
TECH TO TRANSLATE
Discover the scientific and technological innovations to support your ATMP getting to market.
On Target
Identifying the best targets, using AI, BioInformatics and ‘Omics’ approaches to improve biological understanding and predict efficacy and pharmacology for cell and gene therapies.
Prepare for patients
What should you consider when getting an advanced therapy ready for First in Human trials? Does it have the 5Rs: right target, right tissue, right safety, right patient and right commercial potential?
Advancing into the clinic
What do you need to consider to progress advanced therapies through the clinical phase of development?
License to thrill: ATMPs
How do you get a licence to market your ATMP? What to consider when thinking about post-marketing commitments and surveillance.
MAKING IT
Discover how to manufacture your ATMPs, outsourced or in-house, and the process and analytical technology innovation that underpins success.
Innovate to Elevate
Discover how Process Analytical Technology can improve your ATMP manufacturing and scale up.
Matchmaking
How to find the right partner to outsource your manufacturing and the considerations for setting up a productive partnership.
ATMP: house blend
Understand when to keep manufacturing in-house and what you need to consider to make that a success e.g. what expertise and skills are required.
Oh Industry 4.0
How has Industry 4.0 been adopted and where should the focus be? Our panel discusses digitalisation, sensors and automation, security and sustainability.
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.